Equities

YungShin Global Holding Corp

3705:TAI

YungShin Global Holding Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)57.40
  • Today's Change0.40 / 0.70%
  • Shares traded459.29k
  • 1 Year change+31.05%
  • Beta--
Data delayed at least 20 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,8082,0221,252
Total Receivables, Net1,7101,7641,796
Total Inventory2,7732,7193,101
Prepaid expenses146166175
Other current assets, total5.091562
Total current assets6,4426,6876,387
Property, plant & equipment, net3,5663,7654,293
Goodwill, net------
Intangibles, net8.552145
Long term investments1,2281,1591,035
Note receivable - long term------
Other long term assets11059108
Total assets11,51211,85312,009
LIABILITIES
Accounts payable559446494
Accrued expenses--380453
Notes payable/short-term debt9771,5552,001
Current portion long-term debt/capital leases1012817
Other current liabilities, total882510690
Total current liabilities2,4283,0193,655
Total long term debt250148708
Total debt1,2381,8302,726
Deferred income tax392356332
Minority interest572543250
Other liabilities, total528627526
Total liabilities4,1704,6935,471
SHAREHOLDERS EQUITY
Common stock2,6642,6642,664
Additional paid-in capital2,3392,3402,153
Retained earnings (accumulated deficit)2,6902,4702,113
Treasury stock - common(1.44)(1.44)(1.44)
Unrealized gain (loss)362312
Other equity, total(386)(336)(404)
Total equity7,3437,1606,538
Total liabilities & shareholders' equity11,51211,85312,009
Total common shares outstanding266266266
Treasury shares - common primary issue0.060.060.06
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.